|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Net product sales | |||||
| License, collaboration and royalty revenue | |||||
| Total revenue | |||||
| Operating expenses | |||||
| Cost of revenue | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Amortization of intangible assets | |||||
| Restructuring | |||||
| Other expense (income), net | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Net income (loss) before income taxes | |||||
| Income tax (benefit) expense | |||||
| Net income (loss) | |||||
| Other comprehensive income: | |||||
| Unrealized gain on available-for-sale securities | |||||
| Comprehensive income (loss) | |||||
| Earnings (loss) per share | |||||
| Basic (in usd per share) | |||||
| Diluted (in usd per share) | |||||
| Shares used in computing earnings (loss) per share | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...